Amundi decreased its holdings in Ingredion Incorporated (NYSE:INGR - Free Report) by 24.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 107,725 shares of the company's stock after selling 34,557 shares during the period. Amundi owned approximately 0.17% of Ingredion worth $10,203,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. International Assets Investment Management LLC acquired a new stake in Ingredion during the 4th quarter valued at $30,000. GHP Investment Advisors Inc. purchased a new stake in shares of Ingredion during the first quarter worth about $33,000. Bell Investment Advisors Inc acquired a new position in shares of Ingredion in the second quarter worth about $34,000. Los Angeles Capital Management LLC acquired a new position in shares of Ingredion in the fourth quarter worth about $36,000. Finally, Root Financial Partners LLC boosted its holdings in Ingredion by 83.7% in the first quarter. Root Financial Partners LLC now owns 371 shares of the company's stock valued at $42,000 after purchasing an additional 169 shares during the last quarter. 85.27% of the stock is owned by institutional investors and hedge funds.
Ingredion Trading Down 0.8%
NYSE:INGR opened at $100.29 on Friday. Ingredion Incorporated has a 52 week low of $94.44 and a 52 week high of $127.50. The stock's 50 day moving average price is $102.34 and its 200 day moving average price is $105.69. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.92 and a current ratio of 2.80. The company has a market capitalization of $6.32 billion, a P/E ratio of 10.94, a P/E/G ratio of 0.85 and a beta of 0.62.
Ingredion (NYSE:INGR - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $2.82 EPS for the quarter, beating analysts' consensus estimates of $2.71 by $0.11. Ingredion had a return on equity of 15.40% and a net margin of 8.21%.The business had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter in the prior year, the firm posted $2.87 EPS. The firm's revenue for the quarter was up .9% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 10.300-10.900 EPS. On average, research analysts forecast that Ingredion Incorporated will post 10.76 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms have commented on INGR. Oppenheimer downgraded shares of Ingredion from an "outperform" rating to a "market perform" rating in a research note on Monday, June 8th. Benchmark reiterated a "buy" rating on shares of Ingredion in a report on Tuesday, June 9th. UBS Group boosted their price objective on shares of Ingredion from $104.00 to $108.00 and gave the company a "neutral" rating in a research report on Wednesday, August 5th. Weiss Ratings lowered shares of Ingredion from a "hold (c)" rating to a "hold (c-)" rating in a research report on Wednesday, July 8th. Finally, Zacks Research upgraded shares of Ingredion from a "strong sell" rating to a "hold" rating in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, Ingredion currently has a consensus rating of "Hold" and an average target price of $121.29.
Check Out Our Latest Stock Analysis on Ingredion
Insider Buying and Selling
In other news, Director David Fischer sold 1,662 shares of the business's stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $102.31, for a total value of $170,039.22. Following the sale, the director owned 19,930 shares in the company, valued at approximately $2,039,038.30. The trade was a 7.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.
Ingredion Profile
(
Free Report)
Ingredion Incorporated NYSE: INGR is a global ingredient solutions company that develops and produces ingredients derived primarily from corn, tapioca, potato and other plant-based sources. Its products are used by food, beverage, brewing, animal nutrition, pharmaceutical, personal care and industrial manufacturers.
The company's portfolio includes starches, sweeteners, fibers, texturizers, specialty ingredients and plant-based proteins. These ingredients help customers improve the taste, texture, nutrition, stability and performance of finished products, including baked goods, dairy products, beverages, confectionery, sauces and other consumer and industrial goods.
Ingredion serves customers across North America, South America, Asia-Pacific, Europe, the Middle East and Africa.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.